SKP1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 9.952600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
4.247400E-01
Normal-vs-Stage2
9.131000E-01
Normal-vs-Stage3
4.313200E-01
Normal-vs-Stage4
7.447200E-01
Stage1-vs-Stage2
1.790040E-01
Stage1-vs-Stage3
7.191500E-02
Stage1-vs-Stage4
6.471000E-01
Stage2-vs-Stage3
1.562000E-01
Stage2-vs-Stage4
5.280400E-01
Stage3-vs-Stage4
2.299400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
9.918600E-01
Normal-vs-AfricanAmerican
9.296000E-01
Normal-vs-Asian
9.148600E-01
Caucasian-vs-AfricanAmerican
8.987200E-01
Caucasian-vs-Asian
8.055800E-01
AfricanAmerican-vs-Asian
9.648000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
9.889200E-01
Normal-vs-Female
9.773600E-01
Male-vs-Female
8.706000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
7.201400E-01
Normal-vs-Age(41-60Yrs)
4.784000E-01
Normal-vs-Age(61-80Yrs)
7.617600E-01
Normal-vs-Age(81-100Yrs)
6.068000E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
8.356200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
4.596000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
1.807420E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
8.039700E-04
Age(41-60Yrs)-vs-Age(81-100Yrs)
3.956700E-03
Age(61-80Yrs)-vs-Age(81-100Yrs)
9.123800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
6.815600E-01
Normal-vs-Daily Drinker
9.665200E-01
Normal-vs-Weekly Drinker
3.261000E-01
Normal-vs-Occasional Drinker
5.697600E-01
Normal-vs-Social Drinker
9.094800E-01
Non Drinker-vs-Daily Drinker
4.431200E-01
Non Drinker-vs-Weekly Drinker
3.300600E-01
Non Drinker-vs-Occasional Drinker
4.416100E-02
Non Drinker-vs-Social Drinker
2.973600E-01
Daily Drinker-vs-Weekly Drinker
1.227010E-01
Daily Drinker-vs-Occasional Drinker
2.232800E-01
Daily Drinker-vs-Social Drinker
7.954200E-01
Weekly Drinker-vs-Occasional Drinker
1.236290E-02
Weekly Drinker-vs-Social Drinker
4.097600E-02
Occasional Drinker-vs-Social Drinker
3.057000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
4.495600E-02
Normal-vs-Grade 2
1.224030E-03
Normal-vs-Grade 3
4.240000E-04
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
8.535600E-01
Grade 1-vs-Grade 3
7.675600E-01
Grade 1-vs-Grade 4
4.495600E-02
Grade 2-vs-Grade 3
8.340000E-01
Grade 2-vs-Grade 4
1.224030E-03
Grade 3-vs-Grade 4
4.240000E-04
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
6.923000E-01
Normal-vs-NonDiabetic
9.473600E-01
Diabetic-vs-NonDiabetic
1.779980E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
5.781000E-01
Normal-vs-NoPancreatitis
9.600200E-01
Pancreatitis-vs-NoPancreatitis
2.895800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
7.621400E-01
Normal-vs-N1
8.884000E-01
N0-vs-N1
1.162600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
5.879200E-01
Normal-vs-TP53-NonMutant
9.477200E-01
TP53-Mutant-vs-TP53-NonMutant
1.433990E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
